1 of 2 FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)
2 of 2 FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers
FDA authorizes Moderna COVID-19 vaccine for emergency use
By Matthew Perrone and Lauran Neergaard
Published
FDA advisory committee votes to recommend emergency use of Moderna COVID-19 vaccine
A key advisory committee to the FDA on Thursday voted to recommend the approval of Moderna’s COVID-19 vaccine for emergency use, one of the final hurdles before FDA authorization.
WASHINGTON - The U.S. Food and Drug Administration authorized Moderna’s coronavirus vaccine for emergency use on Friday, the second vaccine to be approved by U.S. regulators to prevent severe COVID-19 illness.
FDA Commissioner Stephen M. Hahn, called the approval another crucial step in the fight against this global pandemic.
2nd COVID-19 vaccine set for OK in US with panel endorsement wmal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wmal.com Daily Mail and Mail on Sunday newspapers.
By Press Association 2021
Nurse Kathe Olmstead, right, gives a volunteer an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna
The head of the Food and Drug Administration (FDA) has said his agency will move to quickly authorise a second Covid-19 vaccine for the US to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA commissioner Stephen Hahn said in a statement that regulators have communicated their plans to pharmaceutical company Moderna, which co-developed the vaccine with the National Institutes of Health.
The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18-years-old and up.
FDA expected to greenlight Moderna s COVID-19 vaccine: HHS Secretary Alex Azar 6abc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 6abc.com Daily Mail and Mail on Sunday newspapers.